プロヒビチン
McClung JK, Jupe ER, Liu XT, Dell'Orco RT (1996). “Prohibitin: potential role in senescence, development, and tumor suppression”. Exp. Gerontol. 30 (2): 99–124. doi:10.1016/0531-5565(94)00069-7. PMID 8591812.
Dell'Orco RT, McClung JK, Jupe ER, Liu XT (1996). “Prohibitin and the senescent phenotype”. Exp. Gerontol. 31 (1–2): 245–52. doi:10.1016/0531-5565(95)02009-8. PMID 8706794.
Mishra S, Murphy LC, Nyomba BL, Murphy LJ (2005). “Prohibitin: a potential target for new therapeutics”. Trends in molecular medicine 11 (4): 192–7. doi:10.1016/j.molmed.2005.02.004. PMID 15823758.
Rajalingam K, Rudel T (2007). “Ras-Raf signaling needs prohibitin”.
(1995). “Regions of evolutionary conservation between the rat and human prohibitin-encoding genes”. Gene 158 (2): 291–4. doi:10.1016/0378-1119(95)00164-2. PMID 7607556.
Ikonen E, Fiedler K, Parton RG, Simons K (1995). “Prohibitin, an antiproliferative protein, is localized to mitochondria”. FEBS Lett. 358 (3): 273–7. doi:10.1016/0014-5793(94)01444-6. PMID 7843414.
Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
Sato T, Sakamoto T, Takita K et al. (1993).